Switch to:
More From Other Websites
Former CEO of Trius Therapeutics Publishes New Blog Entitled “FDA Drug Approvals: Congress Giveth... Oct 08 2013
Regeneron (REGN) a Biotech Success Story: Growth and Opportunities from Ocular Drug and a... Sep 19 2013
TRIUS THERAPEUTICS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Sep 11 2013
Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics Sep 11 2013
Cubist Pharmaceuticals Announces Results of Tender Offer for Outstanding Shares of Trius... Sep 11 2013
Scientific Conferences Create Buzz And Move Biotech Stocks: Michael King Sep 06 2013
Cubist Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of Trius Aug 29 2013
Trius Therapeutics price target raised to $15 from $10 at Leerink Aug 16 2013
TRIUS THERAPEUTICS INC Financials Aug 15 2013
Cubist Pharmaceuticals' Strategic Acquisitions Are Great For Investors Aug 14 2013
Upcoming Catalyst Could Spark Another Run For Insmed Aug 14 2013
TRIUS THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report Aug 07 2013
TRIUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 06 2013
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Trius Therapeutics,... Aug 06 2013
The Best- And Worst-Performing Biotech Stocks July 26 To August 2 Aug 04 2013


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide